首页> 外文OA文献 >PES14 RESPONSIVENESS OF SELF-REPORTED VISUAL FUNCTIONING IN AGE-RELATED MACULAR DEGENERATION (AMD) PATIENTS TO GENERAL HEALTH AND CHANGES IN VISUAL ACUITY IN A PHASE I/II RANDOMIZED CONTROLLED TRIAL OF LUCENTISTM (RANIBIZUMAB; RHUFAB V2)

【2h】

PES14 RESPONSIVENESS OF SELF-REPORTED VISUAL FUNCTIONING IN AGE-RELATED MACULAR DEGENERATION (AMD) PATIENTS TO GENERAL HEALTH AND CHANGES IN VISUAL ACUITY IN A PHASE I/II RANDOMIZED CONTROLLED TRIAL OF LUCENTISTM (RANIBIZUMAB; RHUFAB V2)

机译：PES14在年龄相关的黄斑变性（AMD）患者中I / II随机控制的LUCENTISTM试验（RANIBIZUMAB； RHUFAB V2）中一般报告的视觉功能对一般健康和视觉敏锐度的响应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Globe D; Tonnu IQ; Chang TS; Fine J;
展开▼
作者单位

展开▼
年度 2004
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration A Randomized Clinical Trial [J] . Gillies Mark C., Hunyor Alex P., Arnold Jennifer J., JAMA ophthalmology . 2019,第4期

机译：Ranibizumab和AfliBelcept对治疗和延伸的最佳矫正视力的影响，用于新生血管年龄相关的黄斑变性随机临床试验
2. Two year visual outcomes in patients with neovascular age-related macular degeneration treated with ranibizumab stratified by patient age and baseline visual acuity [J] . Hearne Elewys, Afshar Farid, Fletcher Emily, Investigative ophthalmology & visual science . 2016,第12期

机译：用患者年龄和基线视力分层治疗的新生血管年龄相关黄斑化患者的两年视觉结果
3. The effect of fellow eye visual acuity on visual acuity of study eyes receiving ranibizumab for age-related macular degeneration [J] . ZweifelS.A., SarojN., ShapiroH., Retina . 2012,第7期

机译：同眼视力对接受兰尼单抗治疗与年龄有关的黄斑变性的研究眼睛视力的影响
4. Associations among comorbidities, visual acuity, and quality of life in patients with age-related macular degeneration and central vision loss. [D] . Miskala, Paivi Helena. 2002

机译：与年龄相关的黄斑变性和中心视力丧失的患者的合并症，视敏度和生活质量之间的关联。
5. Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized phase IIIb OCTAVE study [O] . Giovanni Staurenghi, Justus G. Garweg, Bianca S. Gerendas, 2020

机译：新血管性年龄相关性黄斑变性患者的功能功能和解剖学标准指导的兰尼单抗治疗–来自IIIb期OCTAVE随机研究的结果
6. Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study [O] . Giovanni Staurenghi, Justus G. Garweg, Bianca S. Gerendas, 2020

机译：功能性与功能性和解剖标准标准引导的ranibizumab治疗在患有新血管年龄相关的黄斑变性的患者 - 来自随机，IIIB阶段延期研究的结果

PES14 RESPONSIVENESS OF SELF-REPORTED VISUAL FUNCTIONING IN AGE-RELATED MACULAR DEGENERATION (AMD) PATIENTS TO GENERAL HEALTH AND CHANGES IN VISUAL ACUITY IN A PHASE I/II RANDOMIZED CONTROLLED TRIAL OF LUCENTISTM (RANIBIZUMAB; RHUFAB V2)

著录项

引文网络

相似文献

相关主题

期刊订阅